Do peptides help with sleep disorders?
3 peptides are graded for sleep disorders on this page. The strongest grade is human RCT evidence, for tirzepatide and DSIP (delta sleep-inducing peptide). Each one is weighed against the standard of care below, and the evidence table gives the grade and a note for every peptide.
What is the standard of care for sleep disorders?
Cognitive behavioral therapy for insomnia as first line; sleep hygiene; CPAP or oral appliances for obstructive sleep apnea; short term hypnotics when needed.
Any peptide below should be judged against this baseline, not against doing nothing. Talk to a licensed provider before replacing or adding to an established treatment.
Which peptides have been studied for sleep disorders?
Ordered by strength of evidence for this use. Grades follow the methodology; each peptide page lists the individual studies.
| Peptide | Evidence for this use | Note |
|---|---|---|
| Tirzepatide | Evidence: Human RCT evidence | FDA approved for moderate to severe obstructive sleep apnea in obesity (December 2024). [2] |
| DSIP (delta sleep-inducing peptide) | Evidence: Human RCT evidence | Small, older randomized placebo-controlled trials in insomnia with inconsistent results on sleep measures; FDA's July 2026 PCAC briefing recommended against 503A listing, and news reports did not name it among the peptides the committee voted to recommend. [1] |
| Epitalon | Evidence: Human observational evidence | Marketed for melatonin and circadian effects; two Russian human studies reported higher melatonin output, but their abstracts do not state design or sample size, and both measured melatonin, not sleep. [1] [3] [4] |
Cost and access
Price ranges, lawful channels, and insurance notes for peptides graded here. State rules are in the legal guides by state.
Frequently asked questions
Are there peptides for sleep?
DSIP (delta sleep-inducing peptide) is the only peptide marketed specifically for sleep, and its evidence is weak: small, older placebo-controlled trials in insomnia gave inconsistent results, FDA lists its compounding nomination as withdrawn, and FDA's July 2026 compounding advisory committee briefing recommended against adding it to the 503A bulks list. Epitalon is marketed for melatonin and circadian effects; two Russian human studies reported higher melatonin output, but their abstracts do not state design or sample size, and both measured melatonin, not sleep. The one peptide approved for a sleep disorder is tirzepatide (Zepbound), for moderate to severe obstructive sleep apnea in adults with obesity. [1] [2] [3] [4]
Is DSIP legal?
DSIP is not an FDA approved drug. FDA lists its nomination as withdrawn, FDA's July 2026 advisory committee briefing recommended against listing it, and it is not on the 503A bulks list, so a pharmacy has no federal basis to compound it from bulk. [1] [5]
Is any peptide FDA approved for sleep disorders?
Tirzepatide is an FDA approved drug, but an approval covers only the indications on that label, so check the label before assuming it applies to sleep disorders. The other peptides graded here are not FDA approved. [2] [5]
Has any peptide been tested in a randomized trial for sleep disorders?
Yes, for tirzepatide and DSIP (delta sleep-inducing peptide). Check each note for the population and endpoints: a randomized trial in a related group or on a surrogate marker is weaker than one on the outcome you care about. [1] [2]
From the blog
- Epitalon human studies: what the small cohorts actually measured
Most epitalon human data come from one group and used the pineal extract Epithalamin, not synthetic epitalon. What each study measured, the claimed benefits versus the evidence, and side effects.
Sources
- [1]FDA Pharmacy Compounding Advisory Committee meetings (July 2026 meeting on peptide nominations)FDA, 2026
- [2]FDA prescribing information for Zepbound (tirzepatide), via DailyMedFDA, 2025
- [3]Normalizing effect of the pineal gland peptides on the daily melatonin rhythm in old monkeys and elderly peoplePubMed 17969590, 2007
- [4]AEDG peptide regulates human circadian rhythms genes expression during pineal gland accelerated agingPubMed 33280326, 2020
- [5]Drugs@FDA: FDA-approved drugs databaseFDA